Koyfin Home > Directory > Health Care > Abbvie Inc > Repurchase of Common Stock

Abbvie Inc Repurchase of Common Stock Chart (ABBV)

Abbvie Inc annual/quarterly Repurchase of Common Stock from 2013 to 2020.
  • Abbvie Inc Repurchase of Common Stock for the quarter ending September 09, 2020 was $-20m a 90.00% decrease of -18m year over year
  • Abbvie Inc Repurchase of Common Stock for the last 12 months ending September 09, 2020 was $-684m a 8.04% decrease of -55m year over year
  • Abbvie Inc Annual Repurchase of Common Stock for 2019 was $-629m a -1,810.02% increase of 11,385m from 2018
  • Abbvie Inc Annual Repurchase of Common Stock for 2018 was $-12,014m a 88.26% decrease of -10,604m from 2017
  • Abbvie Inc Annual Repurchase of Common Stock for 2017 was $-1,410m a -327.87% increase of 4,623m from 2016
Other Cash Flow Metrics:
  • Abbvie Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $4,524m a 42.88% increase of 1,940m year over year
  • Abbvie Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $3,124m a 76.27% increase of 2,383m year over year
  • Abbvie Inc Total Revenue for the quarter ending December 12, 2018 was $8,305m a 4.47% increase of 371m year over year
View Chart On Koyfin

Quarterly ABBV Repurchase of Common Stock Data

09/2020$-20m
06/2020$-19m
03/2020$-643m
12/2019$-2m
09/2019$-4m
06/2019$-3m
03/2019$-620m
12/2018$-2,058m
09/2018$-1,009m
06/2018$-7,516m

Annual ABBV Repurchase of Common Stock Data

2019$-629m
2018$-12,014m
2017$-1,410m
2016$-6,033m
2015$-7,586m
2014$-665m
2013$-320m